News on Pfizer (Ticker: PFE) continually updated from thousands of sources around the net.
2 hrs ago | Law.com
A once-gigantic investor class action over Pfizer Inc.'s marketing of the painkillers Celebrex and Bextra finally met its demise on Tuesday, just two months before the decade-old case was scheduled for trial.
Trending on the Topix Network
6 hrs ago | Barron's
On July 1, Salix Pharmaceuticals jumped 14% after announcing positive results from a drug trial .
The ruling by U.S. District Judge Laura Taylor Swain in New York came ahead of a Sept.
People trying to quit smoking may be more likely to succeed if they combine the patch with a pill, suggests a new study from South Africa.
U.S. health-care companies like AbbVie are stepping up efforts to merge with rivals from overseas, seeking to benefit from lower tax rates in countries like the UK and Ireland.
Eli Lilly and Company et al. v. Panacea Biotec, Ltd. 1:14-cv-01064; filed June 26, 2014 in the Southern District of Indiana Infringement of certain of U.S. Patent Nos.
The Durst Organization, whose properties include One Bryant Park is scoring a rare 30-year condo commitment at 205 East 42nd Street.
At any given moment, there are literally hundreds of severely undervalued companies that are ripe for takeovers.
Stream or download at http://greatspeechesandinterviews.blogspot.com/ Broadcast at Access Sacramento, Sundays 6-8pm PDT at http://www.live365.com/stations/accesssacramento?site=pro Author and journalist Matt Taibbi speaks to a crowd of Occupy Wall Street protestors after a march on the offices of pharmaceutical giant Pfizer, Wednesday, Feb. 29, ... (more)
The executives at Pfizer PFE -0.07% and Johnson & Johnson JNJ -0.32% are giving each other headaches over an ad for a widely used pain reliever.
THE Nigerian judiciary was jolted last year by a suit filed by the so-called Trovan Victims Association, TVA, represented by Mustapha Maisekeli and their lawyers against Pfizer Inc., Pfizer Specialties Limited, the Healthcare Meningitis Trust Fund, Chief Anthony Idigbe and Bode Technology Inc. In the case, the plaintiffs accused the respondents of ... (more)
BIND Therapeutics, Inc. , a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called AccurinsTM, announced today the completion of its collaborative research program with Amgen Inc. originally entered into in January 2013.
Wall Street lingered near record highs as investors awaited the government's jobs report, due on Thursday, after stronger-than-expected private jobs data underpinned the view that the world's largest economy is in better shape than thought.
Alnylam Pharmaceuticals, Inc . , a leading RNAi therapeutics company, announced today the election of Amy W. Schulman to its Board of Directors.
Updated: Wed Jul 09, 2014 09:59 pm
Copyright © 2014 Topix LLC